These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 18779441)
1. Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005. Conen D; Torres J; Ridker PM Circulation; 2008 Sep; 118(13):1321-7. PubMed ID: 18779441 [TBL] [Abstract][Full Text] [Related]
2. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. Ridker PM; Torres J JAMA; 2006 May; 295(19):2270-4. PubMed ID: 16705108 [TBL] [Abstract][Full Text] [Related]
3. Association of industry sponsorship to published outcomes in gastrointestinal clinical research. Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and factors associated with use of placebo control groups in randomized controlled trials in psoriasis: a cross-sectional study. Katz KA; Karlawish JH; Chiang DS; Bognet RA; Propert KJ; Margolis DJ J Am Acad Dermatol; 2006 Nov; 55(5):814-22. PubMed ID: 17052487 [TBL] [Abstract][Full Text] [Related]
6. The roles of funding source, clinical trial outcome, and quality of reporting in orthopedic surgery literature. Khan SN; Mermer MJ; Myers E; Sandhu HS Am J Orthop (Belle Mead NJ); 2008 Dec; 37(12):E205-12; discussion E212. PubMed ID: 19212579 [TBL] [Abstract][Full Text] [Related]
7. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction. Rochon PA; Clark JP; Binns MA; Patel V; Gurwitz JH CMAJ; 1998 Aug; 159(4):321-7. PubMed ID: 9732709 [TBL] [Abstract][Full Text] [Related]
8. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis. Falk Delgado A; Falk Delgado A Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317 [TBL] [Abstract][Full Text] [Related]
9. Citations to trials of nicotine replacement therapy were biased toward positive results and high-impact-factor journals. Etter JF; Stapleton J J Clin Epidemiol; 2009 Aug; 62(8):831-7. PubMed ID: 19128941 [TBL] [Abstract][Full Text] [Related]
10. Association between funding source and study outcome in orthopaedic research. Leopold SS; Warme WJ; Fritz Braunlich E; Shott S Clin Orthop Relat Res; 2003 Oct; (415):293-301. PubMed ID: 14612659 [TBL] [Abstract][Full Text] [Related]
11. Publication Speed, Reporting Metrics, and Citation Impact of Cardiovascular Trials Supported by the National Heart, Lung, and Blood Institute. Gordon D; Cooper-Arnold K; Lauer M J Am Heart Assoc; 2015 Jul; 4(8):e002292. PubMed ID: 26231845 [TBL] [Abstract][Full Text] [Related]
12. The demise of the randomised controlled trial: bibliometric study of the German-language health care literature, 1948 to 2004. Galandi D; Schwarzer G; Antes G BMC Med Res Methodol; 2006 Jul; 6():30. PubMed ID: 16824217 [TBL] [Abstract][Full Text] [Related]
13. Characteristics associated with citation rate of the medical literature. Kulkarni AV; Busse JW; Shams I PLoS One; 2007 May; 2(5):e403. PubMed ID: 17476325 [TBL] [Abstract][Full Text] [Related]
14. Association between research sponsorship and study outcome in plastic surgery literature. Momeni A; Becker A; Bannasch H; Antes G; Blümle A; Stark GB Ann Plast Surg; 2009 Dec; 63(6):661-4. PubMed ID: 19887933 [TBL] [Abstract][Full Text] [Related]
15. NIH clinical trials and publication bias. Dickersin K; Min YI Online J Curr Clin Trials; 1993 Apr; Doc No 50():[4967 words; 53 paragraphs]. PubMed ID: 8306005 [TBL] [Abstract][Full Text] [Related]
16. Funding, disease area, and internal validity of hepatobiliary randomized clinical trials. Kjaergard LL; Gluud C Am J Gastroenterol; 2002 Nov; 97(11):2708-13. PubMed ID: 12425537 [TBL] [Abstract][Full Text] [Related]
17. Representation of women in randomized clinical trials of cardiovascular disease prevention. Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159 [TBL] [Abstract][Full Text] [Related]
18. International collaboration, funding and association with burden of disease in randomized controlled trials in Africa. Swingler GH; Pillay V; Pienaar ED; Ioannidis JP Bull World Health Organ; 2005 Jul; 83(7):511-7. PubMed ID: 16175825 [TBL] [Abstract][Full Text] [Related]
19. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? Als-Nielsen B; Chen W; Gluud C; Kjaergard LL JAMA; 2003 Aug; 290(7):921-8. PubMed ID: 12928469 [TBL] [Abstract][Full Text] [Related]
20. Do financial factors such as author page charges and industry funding impact on the nature of published research in infectious diseases? Liyanage SS; Raina Macintyre C Health Info Libr J; 2006 Sep; 23(3):214-22. PubMed ID: 16911128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]